Donate

Latest news & articles

Latest news
$3 million invested to understand and prevent the development of T1D
Research

$3 million invested to understand and prevent the development of T1D

JDRF Australia and The Leona M. and Harry B. Helmsley Charitable Trust (Helmsley) have committed $3 million for research projects aimed at understanding how type 1 diabetes (T1D) develops, with the ultimate goal of preventing it. This is in collaboration with the Environmental Determinants of Islet Autoimmunity (ENDIA) Study. ENDIA is the world’s first T1D observational […]
Type 1 diabetes research breakthrough shows insulin-producing cells can be regenerated
Research

Type 1 diabetes research breakthrough shows insulin-producing cells can be regenerated

We could be one step closer to replacing the need for regular insulin injections in people living with type 1 diabetes (T1D), thanks to JDRF-funded Australian research that was published this week in the prestigious Nature journal. Why is this research important? During T1D development, the immune system mistakenly attacks the insulin-producing beta cells in […]
World-first Australian clinical trial shows promise for suppressing progression of type 1 diabetes in those newly diagnosed
Research

World-first Australian clinical trial shows promise for suppressing progression of type 1 diabetes in those newly diagnosed

  A JDRF-funded, world-first clinical trial has shown that a commonly prescribed rheumatoid arthritis drug (baricitinib) can preserve the body’s own insulin production and suppress the progression of type 1 diabetes (T1D) in those newly diagnosed with the condition. This comes after three decades of research out of the St Vincent’s Institute (SVI) in Melbourne, […]
New research funding may allow those with type 1 diabetes to make insulin again
Research

New research funding may allow those with type 1 diabetes to make insulin again

JDRF has just funded a new Australian islet transplantation research project with the potential to revert type 1 diabetes. The benefits of islet transplantation Pancreatic islet transplantation is a life-saving and life-changing treatment currently available for people with type 1 diabetes (T1D) who are unaware of their dangerously low blood glucose levels (known as ‘severe […]
Regenerating damaged beta cells in type 1 diabetes: new funding announced
Research

Regenerating damaged beta cells in type 1 diabetes: new funding announced

JDRF has funded a new Australian research project which may allow those with type 1 diabetes (T1D) to regenerate lost pancreatic cells. During T1D development, the immune system mistakenly attacks the insulin-producing beta cells in the pancreas. This leads to the loss and destruction of beta cells, meaning that people with T1D are no longer […]
Research breakthrough shows that antivirals can delay T1D progression
Research

Research breakthrough shows that antivirals can delay T1D progression

A new study suggests that giving antivirals shortly after a type 1 diabetes (T1D) diagnosis may preserve the body’s ability to produce insulin. Recent results from a clinical trial published in the prestigious Nature journal have suggested that administering the antivirals pleconaril and ribavirin can preserve beta cell function in children and teenagers recently diagnosed […]
Type 1 diabetes screening pilot rolls out in primary school for the first time
Research

Type 1 diabetes screening pilot rolls out in primary school for the first time

This World Diabetes Day, on Tuesday 14th November, students from kindergarten and year 4 at Inaburra School in Sydney’s south participated in screening to detect type 1 diabetes (T1D). This is part of the JDRF-funded Australian Type 1 Diabetes National Screening Pilot, a research project looking to identify early-stage T1D in childhood. It was the first […]
Teplizumab shown to slow down type 1 diabetes in those newly diagnosed
Research

Teplizumab shown to slow down type 1 diabetes in those newly diagnosed

Research findings have just been released for the PROTECT clinical trial which tested whether the disease-modifying therapy Teplizumab is able to delay type 1 diabetes (T1D) progression in those newly diagnosed. What is Teplizumab?  Teplizumab is a therapy which has been shown to delay the progression from an early stage of T1D (Stage 2) to […]
Talking with David de George, PhD researcher and Career Support and Travel Grant Recipient
Research

Talking with David de George, PhD researcher and Career Support and Travel Grant Recipient

JDRF Australia’s Career Support and Travel Grants for domestic and international travel are designed to support the next generation of type 1 diabetes (T1D) researchers. They allow early to mid-career researchers and allied health professionals to gain new skills, exchange knowledge, and establish connections and collaborations. We recently spoke to David de George, PhD student […]
Innovate in the world of type 1 diabetes: join the Commercialisation Essentials Workshop
Research

Innovate in the world of type 1 diabetes: join the Commercialisation Essentials Workshop

Are you passionate about creating a world where research breakthroughs in type 1 diabetes (T1D) are rapidly turned into tangible treatments; a world where the most promising discoveries don’t just remain in labs but make their way swiftly to those who need them the most? Do you have a pioneering research project, innovative idea, or […]
New clinical trial looking for newly diagnosed children and young adults with T1D
Research

New clinical trial looking for newly diagnosed children and young adults with T1D

In people newly diagnosed with type 1 diabetes (T1D) there is often a ‘honeymoon’ phase where some pancreatic beta cells are still able to produce insulin. Committed to improving the lives of those with T1D, JDRF has invested in several clinical studies under the Australasian Type 1 Diabetes Immunotherapy Collaborative (ATIC),  investigating whether we can […]
JDRF’s Research Symposium: Bringing researchers together to celebrate past and future type 1 diabetes breakthroughs
Research

JDRF’s Research Symposium: Bringing researchers together to celebrate past and future type 1 diabetes breakthroughs

Bringing researchers together to celebrate past and future type 1 diabetes breakthroughs On the 24th and 25th July 2023, JDRF Australia was delighted to host a research symposium: T1Decade of Research Progress – Past & Future to commemorate over a decade of achievements of the Type 1 Diabetes Clinical Research Network (T1DCRN). The T1DCRN is […]
2023 JDRF Australia PhD scholarships announced
Research

2023 JDRF Australia PhD scholarships announced

JDRF Australia is delighted to announce the recipients of our 2023 PhD top-up scholarships: Rachel Hicks from Western Sydney University and Amanda Purcell from The Kolling Institute. The top-up scholarship is designed to support and encourage PhD students pursuing research in the field of type 1 diabetes (T1D) in line with JDRF’s mission – to […]
JDRF Australia and Cicada Innovations partner to progress research breakthroughs
Research

JDRF Australia and Cicada Innovations partner to progress research breakthroughs

JDRF Australia is excited to announce our partnership with Cicada Innovations, leaders in deep tech incubation to accelerate scientific progress and bridge translation gaps. Our partnership will accelerate type 1 diabetes (T1D) research translation and commercialisation through providing resources, mentorship, funding, and networking opportunities. Our goal is to bring scientific discoveries into real-world solutions for […]
Drug Verapamil shown to slow T1D progression in newly diagnosed
News

Drug Verapamil shown to slow T1D progression in newly diagnosed

A new study has shown drug Verapamil, regularly used to treat blood pressure, can slow type 1 diabetes progression in newly diagnosed children and teens. As researchers work to cure type 1 diabetes (T1D), the ultimate goal is to prevent the destruction of beta cells that produce insulin. A new JDRF-funded clinical trial reveals a […]
$12M invested to progress landmark ENDIA study
News

$12M invested to progress landmark ENDIA study

MEDIA RELEASE Australia leading type 1 diabetes research with $12M invested to progress landmark study  The funding will support the extension of ENDIA, a world-first study seeking to understand the role of environmental triggers from as early as pregnancy for the onset of type 1 diabetes (T1D). 4 April 2023: JDRF Australia and funding partner […]
Dr. Ki Wook Kim On Developing Vaccines To Prevent Type 1 Diabetes
Research

Dr. Ki Wook Kim On Developing Vaccines To Prevent Type 1 Diabetes

“The ultimate goal is to help develop vaccines to prevent T1D, as well as antiviral therapeutics to potentially treat people already diagnosed with T1D” Dr Kim’s work aims to uncover the link between viruses and type 1 diabetes (T1D). As one of the lead investigators of ENDIA, Dr Kim is looking at whether early infection […]
Talking with Dr Aveni Haynes: Research into early detection of T1D in young children at risk
Research

Talking with Dr Aveni Haynes: Research into early detection of T1D in young children at risk

We sat down with Dr Aveni Haynes to hear from a woman in STEM who inspires in the world of type 1 diabetes (T1D).  What drew you to a career in T1D research? “While training to become a doctor, I was fascinated by the complexity and ingenuity of the human body and to date I […]